MannKind share price logo

MannKind

NASDAQ: MNKD

Small Cap

$3.04

-0.15

(-4.55%)

as on

MannKind Stock Performance

as on October 17, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $3.02
    $3.24
    downward going graph

    0.66%

    Downside

    6.58%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.23
    $6.51
    downward going graph

    26.64%

    Downside

    114.14%

    Upside

    downward going graph

MannKind share price movements today

Previous Close
$3.19
Open
$3.24
Volume
2.2M
Market Cap
$971.1M
Day's Low - High
$3.02 - $3.24
52 Week Low - High
$2.23 - $6.51

MannKind Historical Returns

1 Month Return
-10.14 %
3 Month Return
-21.04 %
1 Year Return
-40.37 %
3 Year Return
-22.2 %
5 Year Return
-37.33 %

MannKind Stock Fundamentals & Key Indicators

Check MannKind market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$971.1M

EPS (TTM)

-0.1395

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.35%

PE Ratio (TTM)

-21.65

Industry PE ratio

-6.87

PEG Ratio

0.19

EBITDA

30.1M

Revenue (TTM)

393.6M

Profit Margin

75.69%

Return On Equity TTM

78.60%

MannKind vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of MannKind with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
MannKind image
MannKind
Buy$971.1M-37.33%-21.6575.69%0.00%
Moderna image
Moderna
Neutral$90.3B-27.05%-29.64-12.57%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$126.4B179.89%28.7886.04%0.00%
Regeneron image
Regeneron
Buy$77.5B43.94%19.0184.86%0.48%

Stock Returns calculator for MannKind Stock including INR - Dollar returns

The MannKind stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

MannKind investment value today

Current value as on today

₹61,449

Returns

-₹38,551

(-38.55%)

Returns from MannKind Stock

-₹43,178 (-43.18%)

Dollar Impact

₹4,627 (+4.63%)

Analyst Recommendation on MannKind Stock

Based on 2 analysts

BUY

50.00%

Buy

50.00%

Hold

0.00%

Sell

Based on 2 analysts, 50% of analysts recommend a 'BUY' rating for MannKind. Average target price of $7.84

MannKind Share Price Target

Get share price movements and forecasts by analysts on MannKind.

What analysts predicted

61.22%UPSIDE

Target Price

$7.84

Current Price

$3.04

Analyzed by

2 Analysts

High

$5

Target

$7.84

Low

$4.75

MannKind target price $7.84, a slight upside of 61.22% compared to current price of $3.04. According to 2 analysts rating.

Indian Investors' Interest in MannKind Stock

Search interest for MannKind Stock has increased by 119% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:119% versus previous 30 day period

MannKind Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
66
72
70
76
78
76
82
111
90
109
Gross Profit
47
52
52
57
60
55
61
87
68
79
Operating Income
16
16
12
26
22
5
18
-7
-2
0
EBITDA
21
13
23
18
26
9
17
-3
2
13
Interest Expense
9
12
8
7
10
6
7
13
12
11
Depreciation
1
2
2
2
2
2
2
4
6
6
Income Before Tax
10
-1
12
8
13
0
7
-20
-16
-19
Income Tax Expense
0
0
1
1
0
0
0
-4
0
0
Net Income
10
-2
11
7
13
0
7
-15
-16
-19
Net Profit Margin
71.93%
71.85%
74.28%
74.47%
77.65%
73.12%
75.40%
78.45%
75.78%
72.99%

MannKind Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
11
27
63
65
75
99
198
285
348
Gross Profit
-5
7
35
40
36
42
136
208
287
Operating Income
-108
-76
-44
-47
-47
-64
8
72
38
EBITDA
-100
-75
-38
-44
-61
-56
16
77
27
Interest Expense
13
9
10
9
16
24
25
37
13
Depreciation
3
1
2
3
3
6
5
8
12
Income Before Tax
-117
-86
-51
-57
-80
-87
-10
30
1
Income Tax Expense
0
0
-
0
-
-
1
2
-4
Net Income
-117
-86
-51
-57
-80
-87
-11
27
5
Net Profit Margin
-46.68%
26.49%
55.62%
62.17%
48.49%
42.37%
68.45%
73.17%
82.47%

MannKind Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
10
-2
11
7
13
0
7
-15
-16
-19
Operating Cash Flow
6
3
9
22
-6
8
23
-7
-5
-18
Investing Cash Flow
-48
-55
-41
48
5
6
-25
-291
18
17
Financing Cash Flow
-3
-44
-2
-86
1
-5
71
247
-35
0
Change in Cash
-45
-95
-34
-16
0
9
70
-52
-22
0

MannKind Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-117
-86
-51
-57
-80
-87
-11
27
5
Operating Cash Flow
-64
-37
-88
-28
-61
-80
34
42
18
Investing Cash Flow
16
0
-22
15
-151
4
-1
-96
-304
Financing Cash Flow
73
61
69
49
270
21
136
-137
315
Change in Cash
25
23
-41
36
57
-54
168
-191
28

Global Institutional Holdings in MannKind

Check out the Institutions with significant holdings in MannKind.

Funds
Holdings
Vanguard
4.96%
iShares
4.79%
VANGUARD INDEX FUNDS
3.91%
SPDR
2.80%
Fidelity Salem Street Trust
1.03%
See all

MannKind News & Key Events

    Insights on MannKind

    Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

    • imgPOSITIVE IMPACT

      Revenue Rich

      img

      Revenue is up for the last 2 quarters, 90.17M → 109.37M (in $), with an average increase of 17.6% per quarter

    • imgPOSITIVE IMPACT

      Price Rise

      img

      In the last 6 months, MNKD stock has moved up by 16.0%

    • imgNO EFFECT

      Against Peers

      img

      In the last 3 years, Moderna, Inc. Common Stock has given 157.2% return, outperforming this stock by 179.4%

    • imgNO EFFECT

      Against Peers

      img

      In the last 1 year, Moderna, Inc. Common Stock has given 771.4% return, outperforming this stock by 811.8%

    • imgNEGATIVE IMPACT

      Profit Down

      img

      Netprofit is down for the last 4 quarters, 7.98M → -19.03M (in $), with an average decrease of 106.2% per quarter

    About MannKind

    MannKind Corporation operates as a biopharmaceutical firm, primarily focused on innovating and bringing to market respiratory-delivered treatments. Its efforts are directed towards tackling endocrine system disorders and rare lung conditions within the U.S. market. The company's key product is Afrezza, an inhaled insulin designed to improve glycemic control for adults managing diabetes. MannKind also actively markets Thyquidity, promoting it to adult and pediatric endocrinologists and other healthcare professionals for the treatment of hypothyroidism. In terms of collaborations, MannKind holds a strategic licensing and partnership agreement with United Therapeutics Corporation. Furthermore, it is collaborating with NRx Pharmaceuticals to develop a dry powder formulation of ZYESAMI (aviptadil), which is a synthetic variant of human vasoactive intestinal peptide intended to shield cells from inflammatory processes. Established in 1991, MannKind Corporation's corporate offices are located in Westlake Village, California.
    OrganisationMannKind
    Headquarters1 Casper Street, Danbury, CA, 06810, US
    IndustryBiotechnology
    CEOMichael E. Castagna

    Key Management of MannKind

    Name

    Title

    Mr. Dominic Marasco R.Ph.

    President of Endocrine Business Unit

    Mr. Sanjay Singh M.B.A.

    Executive Vice President of Technical Operations

    Dr. Ajay Ahuja M.B.A., M.D.

    Executive VP & Chief Medical Officer

    Dr. Wassim Fares M.D., M.Sc.

    Senior VP and Therapeutic Area Head of Respiratory & (interim) Cariorenal

    Dr. Michael E. Castagna Pharm.D.

    CEO & Director

    Mr. Christopher B. Prentiss M.B.A.

    Chief Financial Officer

    Dr. David B. Thomson J.D., Ph.D.

    Executive VP, General Counsel & Secretary

    Dr. Stuart A. Tross Ph.D.

    Chief People & Workplace Officer

    FAQs

    What is MannKind share price today?

    MannKind share price today is $3.04 as on at the close of the market. MannKind share today touched a day high of $3.24 and a low of $3.02.

    What is the 52 week high and 52 week low for MannKind share?

    MannKind share touched a 52 week high of $6.51 on and a 52 week low of $2.23 on . MannKind stock price today i.e. is closed at $3.04,which is 53.30% down from its 52 week high and 36.32% up from its 52 week low.

    What is MannKind's market capitalisation today?

    MannKind market capitalisation is $0.00T as on .

    How to invest in MannKind Stock (MNKD) from India?

    1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
    2. Step 2: Search for MannKind on INDmoney app. Click on Buy button.

    What is the minimum amount required to buy MannKind Stock (MNKD) from India?

    Indian investors can start investing in MannKind (MNKD) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
    For example: If you want to invest $10 or ₹949.60 in MannKind stock (as per the Rupee-Dollar exchange rate as on ). Based on MannKind share’s latest price of $3.04 as on October 17, 2026 at 1:29 am IST, you will get 3.2895 shares of MannKind. Learn more about fractional shares .

    What are the returns that MannKind has given to Indian investors in the last 5 years?

    MannKind stock has given -37.33% share price returns and 27.65% dollar appreciation to an Indian investor in the last 5 years.
    Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?